Search - tctmd.com

Displaying 1 - 11 of 11

Sort: Relevancy | Date

Presentation THT 2025

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

Presenter: Milton Packer

February 12, 2025

Presentation THT 2025

A Strategy That Has Created More Confusion Than Clarity.

Presenter: Milton Packer

February 11, 2025

Presentation THT 2025

Obesity: Assessing the Weight of the Evidence

Presenter: Milton Packer

February 11, 2025

Presentation AHA 2024

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

Presenter: Milton Packer

November 16, 2024

Presentation THT 2024

3000 Years in the Making: Traditional Chinese Herbal Medicines for Heart Failure

Presenter: Milton Packer

March 04, 2024

Presentation THT 2023

SGLT2 Inhibitors Have a Unique Mechanism That Accounts for Their Comprehensive Benefits

Presenter: Milton Packer

March 20, 2023

Presentation THT 2022

Featured Lecture: How to Incorporate New Therapies and In What Order -- Ahead of the Guidelines

Presenter: Milton Packer

February 01, 2022

Presentation TVT 2021

There Is No Such Thing as Maximally-Tolerated GDMT: Use a Real-world Approach!

Presenter: Milton Packer

July 20, 2021

Presentation TCT 2019

When Trials Disagree: The COAPT/MITRA-FR Case Study

Presenter: Milton Packer

September 28, 2019

Presentation TCT 2019

Patient Selection for MitraClip in Heart Failure With FMR: What Are the “COAPT Criteria” and Where (if Anywhere) Might They Be Stretched?

Presenter: Milton Packer

September 26, 2019

Presentation TVT 2019

Proportional vs. Disproportional Mitral Regurgitation — The New Paradigm

Presenter: Milton Packer

June 14, 2019

Advertisement

From Obesity to Inflammation: Common Pathways and New Opportunities in HF

A Strategy That Has Created More Confusion Than Clarity.

Obesity: Assessing the Weight of the Evidence

Effect of Tirzepatide on Major Heart Failure Outcomes in Patients With Heart Failure With a Preserved Ejection Fraction and Obesity: The SUMMIT Trial

3000 Years in the Making: Traditional Chinese Herbal Medicines for Heart Failure

SGLT2 Inhibitors Have a Unique Mechanism That Accounts for Their Comprehensive Benefits

Featured Lecture: How to Incorporate New Therapies and In What Order -- Ahead of the Guidelines

There Is No Such Thing as Maximally-Tolerated GDMT: Use a Real-world Approach!

When Trials Disagree: The COAPT/MITRA-FR Case Study

Patient Selection for MitraClip in Heart Failure With FMR: What Are the “COAPT Criteria” and Where (if Anywhere) Might They Be Stretched?

Proportional vs. Disproportional Mitral Regurgitation — The New Paradigm

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content